CCXI Archives - Blue Horseshoe Stocks

Sweeping the Board with Options Runners

Clean Options Sweep:

Amid a huge day for the markets yesterday, our daily options ideas also bore fruit. We’ve missed on exactly one of the many targets we’ve formulated all week, demonstrating a fairly routine level of accuracy for us. Our regular readers are surely accustomed to our high hit rate, and as for all of you newcomers, you will begin to see that we run a pretty tight ship around here. Each day consists of a review of the previous sessions interests, a grouping of fresh options ideas wherever possible, and an extended watchlist of both small and large cap stocks to watch based on their premarket activity.

Yesterday’s premarket report brought three ideas for the day, and those targets were the MRNA Weekly $162.50-167.50 Calls, the SBUX Weekly $84-86 Calls, and the PYPL Weekly $98-101 Calls, with MRNA and SBUX both showing out as the big winners. Here are the intraday moves recorded by our designated plays:

MRNA Weekly $162.50-167.50 Calls
$162.50: 5.75-26.46 (+360%)
$165: 6.15-24.20 (+293%)
$167.50: 3.65-21.70 (+494%)
_____

SBUX Weekly $84-86 Calls
$84: 1.22-4.00 (+228%)
$85: .72-3.15 (+332%)
$86: .37-2.28 (+516%)
_____

PYPL Weekly $98-101 Calls
$98: 3.43-4.60 (+39%)
$99: 2.85-3.95 (+39%)
$100: 2.28-3.28 (+44%)
$101: 1.83-2.67 (+46%)

Fresh Options Ideas:
CI Weekly $277.50-282.50 Calls
COP Weekly $92-93 Calls
BABA Weekly $98-101 Calls
FTNT 08/19 $56-55 Puts

Extended Watchlist:
TOMDF, INND, CYDY, IGEX, INKW, PSWW, GWHP, ILIM, TWOH, HZEN, MF, ALNA, EMBK, GRNA, SOPA, NNVC, XCUR, CCXI, EFSH

Another Excellent Trading Week on the Books

Another Positive Options Performance:

On Wednesday morning, we initiated coverage on a set of SPY Calls, the SPY 10/08 $430-431 Calls which provided instant results, as we were mentioning yesterday. In fact, those fared so well that rolled up to include the SPY 10/08 $436-438 Calls on our watchlist as well.

With yet another bullish session posted by the S&P, we saw impressive new highs in our previously tracked plays as well as some solid single session runs recorded by the updates strikes as well. The moves and total possible gains on all of those contract sets breaks down as follows:

SPY 10/08 $430-431 Calls
$430: 2.24-11.17 (+399%)
$431: 1.82-10.77 (+492%)

SPY 10/08 $436-438 Calls
$436: 3.53-6.15 (+74%)
$437: 2.60-5.35 (+106%)
$437.50: 2.44-4.88 (+100%)
$438: 2.32-4.50 (+94%)

Our other two freshly formulated options plays from yesterday’s report were in the LEVI and HELE chains, and we got some positive activity on the day from those plays as well:

LEVI 10/15 $25-26 Calls
$25: .90-2.01 (+123%)
$26: .50-1.20 (+140%)
_____

HELE 10/15 $220-230 Call
$220: 13.54-17.50 (+29%)
$230: 5.10-8.50 (+67%)

Fresh Options Idea:
TPTX 11/19 $45-50 Calls

American Leisure Holdings, Inc. AMLH – Recap:

To wrap things up during what has been an immensely successful trading week for both options and stocks, we have an update on AMLH. We flagged this play for observation for the first time on Sept. 22nd, and since then it has exhibited a multibag run. From our observed low of .0026, yesterday’s new high of .0074 works out to an increase of 185%

Extended Watchlist:
ENZC, PUGE, CYBL, NBRI, TGGI, NHMD, CBGL, CEI, CCXI, SNDL, EFTR, DATS, PRLD

Blue Horseshoe Stocks: Winning Options Plays & More

Options Recap

Both of our options ideas from yesterday’s morning report ended up providing us with a chance at sizable single-session gains.

Canadian Solar, Inc. CSIQ

We caught CSIQ in the unique position of having just registered a new 52-week low in the previous session, and having its earnings beat expectations yesterday, so jumping on CSIQ Weekly $16.50-18 Calls ended up being a sound strategy right from the outset. The impressive intraday moves were as follows:

$16.50 Calls – Trading Range: 1.20-1.76 – Max Gain: 47%
$17 Calls – Trading Range: .87-1.50 – Max Gain: 72%
$17.50 Calls– Trading Range: .30-.97 – Max Gain: 223%
$18 Calls – Trading Range: .27-.82 – Max Gain: 204%

Macy’s Inc. M

We went bearish on Macy’s yesterday, partly due to the overall downtrend the stock has seen in recent weeks, and as a reaction to yesterday morning’s disappointing earnings call. In this case our target range was the M Weekly $36-34 Puts and hefty gains were available across the board, including a big triple-bagger in the $34’s.

$36 Puts – Trading Range: 1.83-4.37 – Max Gain: 139%
$35.50 Puts – Trading Range: 1.40-3.79 – Max Gain: 171%
$35 Puts– Trading Range: 1.00-3.60 – Max Gain: 260%
$34.50 Puts – Trading Range: .83-2.88 – Max Gain: 247%
$34 Puts – Trading Range: .50-2.58 – Max Gain: 347%

_______

Fresh Ideas: To throw some other options ideas into the mix this morning, we’re going to be adding Monsanto Co. MON Weekly $102-106 Calls and Jack in the Box, Inc. JACK 05/20 $70 and $75 Calls to our track-list.

Cerebain Biotech Corp. CBBT

We put CBBT on our radars last Tuesday after noticing some increased activity in the stock. Since our mention, subsequent to which we observed a low .53, we’ve seen a good bit of progress leading up to yesterday’s high of 1.25. That’s an overall move of 136%

The high came just prior to the closing bell, at which CBBT held a PPS of 1.20 so we’ll continue to monitor the situation carefully. We’ve had success recently with low-float, low-volume plays, and CBBT fits that bill to a tee.

Extended Watchlist:
FTPM, MRNA, BKCT, LXU, ZIOP, CCXI

Blue Horseshoe Stocks: HZNP Options Update & More

Horizon Pharma plc HZNP

Our first idea of the week in yesterday’s premarket report, which was to track the HZNP Weekly $14 and 15 Calls, ended up paying instant dividends. HZNP was coming off of its earnings call as well as highlighting a new 5M share repurchase program.

Both of our targeted sets of contracts experienced significant intraday swing action which traders could have utilized for solid single-session gains. The $14 Calls ran impressively from a low of .88 to a subsequent high of 2.15, for a 144% rip. The $15’s put up a pleasing performance of similar magnitude, trading in a range from .60-1.33, for total possible profits of up to 122%

We identified 16.15 as an indicating point, the breaching of which would signal us to roll up our strike price to $16. That still remains true as we continue along through the week.

Aperture Health, Inc. APRE – Update

We want to provide an update this morning on the recent progress of APRE, which our regular readers will recollect was a point of focus for us beginning a couple of weeks ago. We’ve tracked it over several swings, commenting on the stock’s ability to make volatile moves to the upside. It continues to demonstrate this ability over recent sessions, wherein we’ve observed quite a rush of momentum.

From last Wednesday’s bounce-point of .0188, we’ve now seen a swing of 165% as of yesterday’s new high of .0499 and the stock recorded its highest volume since November. Presently, indicators on the chart seem to be ripe and ready for the possibility of even higher highs. The next key areas of resistance following a nickel are sitting at .08 and .115.

You may also view the highlights of the chart on the following video presentation:

Extended Watchlist:
CCTL, ISLT, ALXA, NOK, CCXI

Blue Horseshoe Stocks: ODP Update, FRO & More

Frontline, Ltd. FRO

The last time we mentioned FRO was early this month, at which time the stock was trading at a low of 1.33. It has been ramping its way up over the past few sessions, making higher highs and higher lows, and we wanted to flag it once again this morning as it is trading up significantly in the premarket.

This morning’s high of 2.15 represents an increase of 61% over the 1.33-low that we observed as recently as Monday. With the heavy early-morning momentum we’re seeing we’ll want to follow along with this play closely today and into next week.

Talisman Energy, Inc. TLM

We’ll keep an eye on TLM today as well based on some heavy premarket activity and the fact that the stock is coming up off of its 52-week lows. We’ve noticed a break on the chart due to a gapdown from around 5.60 to 4.80, and with the stock currently trading in the 4.40’s, we should be on the lookout for it to possibly make a run at filling that gap.

ChemoCentryx, Inc. CCXI

Also popping up on our morning scan is CCXI, which is currently trading feverishly in the premarket on the heels of a PR early this morning regarding positive top line results on one of its products currently in testing.

With the stock up over 100% in early trading, we’re going to be on the lookout for massive profit-taking to potentially drive the price back down where it may set us up to take advantage of a dip-and-rip opportunity.

MOUNTAIN VIEW, Calif., Dec. 12, 2014 (GLOBE NEWSWIRE) — ChemoCentryx, Inc., (CCXI), a clinical-stage biopharmaceutical company focused on autoimmune diseases, inflammatory disorders and cancer, today announced positive top-line 52-week data from its Phase II clinical trial in diabetic nephropathy with CCX140, an inhibitor of the chemokine receptor known as CCR2. >> FULL PR

Office Depot, Inc. ODP

ODP was a good call for yesterday’s session, as it made a solid 8% move on news that a large activist investor took up a significant position in Office Depot while raising its existing stake in Staple stock to 10% total ownership. It is fueling speculation that there could be pressure for a merger between the two, so this is definitely a story we’ll continuously track going forward.

Extended Watchlist:
ONVO, ONTY, DENN, FCEL, UBIQ